KR20230052915A - 케타민을 포함하는 미소 구체 제제 및 이의 제조 방법 및 사용 방법 - Google Patents

케타민을 포함하는 미소 구체 제제 및 이의 제조 방법 및 사용 방법 Download PDF

Info

Publication number
KR20230052915A
KR20230052915A KR1020237008093A KR20237008093A KR20230052915A KR 20230052915 A KR20230052915 A KR 20230052915A KR 1020237008093 A KR1020237008093 A KR 1020237008093A KR 20237008093 A KR20237008093 A KR 20237008093A KR 20230052915 A KR20230052915 A KR 20230052915A
Authority
KR
South Korea
Prior art keywords
microsphere
ketamine
polymeric
polymeric microspheres
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237008093A
Other languages
English (en)
Korean (ko)
Inventor
레이첼 가라스카
켈시 캇
트레이시 리치
Original Assignee
오크우드 레버러토리즈, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오크우드 레버러토리즈, 엘엘씨 filed Critical 오크우드 레버러토리즈, 엘엘씨
Publication of KR20230052915A publication Critical patent/KR20230052915A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
KR1020237008093A 2020-08-18 2021-08-17 케타민을 포함하는 미소 구체 제제 및 이의 제조 방법 및 사용 방법 Pending KR20230052915A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063067068P 2020-08-18 2020-08-18
US63/067,068 2020-08-18
US202163149911P 2021-02-16 2021-02-16
US63/149,911 2021-02-16
PCT/US2021/046220 WO2022040130A1 (en) 2020-08-18 2021-08-17 Microsphere formulations comprising ketamine and methods for making and using the same

Publications (1)

Publication Number Publication Date
KR20230052915A true KR20230052915A (ko) 2023-04-20

Family

ID=80270269

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237008093A Pending KR20230052915A (ko) 2020-08-18 2021-08-17 케타민을 포함하는 미소 구체 제제 및 이의 제조 방법 및 사용 방법

Country Status (10)

Country Link
US (1) US12233165B2 (cg-RX-API-DMAC7.html)
EP (1) EP4199917B1 (cg-RX-API-DMAC7.html)
JP (1) JP7814375B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230052915A (cg-RX-API-DMAC7.html)
CN (1) CN115942935B (cg-RX-API-DMAC7.html)
AU (1) AU2021329820A1 (cg-RX-API-DMAC7.html)
CA (1) CA3191160A1 (cg-RX-API-DMAC7.html)
IL (1) IL300547A (cg-RX-API-DMAC7.html)
TW (1) TWI906350B (cg-RX-API-DMAC7.html)
WO (1) WO2022040130A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3505157T3 (da) 2017-12-29 2022-02-28 Celon Pharma Sa Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression
EP4611729A1 (en) * 2022-10-31 2025-09-10 Oakwood Laboratories, LLC Mixed release profile polymer microsphere formulations comprising octreotide and methods for making and using the same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720859B2 (ja) * 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US5945126A (en) 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US6270802B1 (en) 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
US6291013B1 (en) * 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU6510400A (en) * 1999-08-04 2001-03-05 Oakwood Laboratories L.L.C. Slow release microspheres
US6479007B1 (en) 1999-09-16 2002-11-12 University Technology Corporation Apparatus and method for controlling pore size in polymeric membranes and thin films
KR100392501B1 (ko) 2000-06-28 2003-07-22 동국제약 주식회사 다중 에멀젼법에 의한 서방출성 미립구의 제조방법
WO2002089767A1 (en) * 2001-05-03 2002-11-14 Massachusetts Eye And Ear Infirmary Implantable drug delivery device and use thereof
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US20050260272A1 (en) 2004-05-05 2005-11-24 Alkermes Controlled Therapeutics, Inc. Method of forming microparticles that include a bisphosphonate and a polymer
CA2620374C (en) 2005-09-28 2012-12-11 Thomas Meyer Pharmaceutical compositions for the treatment of inner ear disorders
EP1996243B1 (en) * 2006-01-11 2014-04-23 HyperBranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
US20070292521A1 (en) * 2006-06-20 2007-12-20 Schwitzer Co., Ltd Oral Encapsulated Preparation for Aquatic Animals
US20110027331A1 (en) 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
SG11201404038PA (en) * 2012-02-06 2014-08-28 Univ Nanyang Tech Methods of manufacturing core-shell microparticles, and microparticles formed thereof
WO2013138322A1 (en) * 2012-03-12 2013-09-19 Janssen Pharmaceutica Nv Esketamine for the treatment of treatment-refractory or treatment-resistant depression
EP3368553B1 (en) 2015-10-27 2023-08-02 Purdue Research Foundation Polymer-based therapeutics for inductive browning of fat
SG11202001206YA (en) 2017-09-14 2020-03-30 Agency Science Tech & Res Emulsions, methods and uses thereof
SG11202005896WA (en) 2017-12-22 2020-07-29 Janssen Pharmaceuticals Inc Esketamine for the treatment of depression
EP3968979B1 (en) 2019-05-15 2026-07-01 Bexson Biomedical, Inc. KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
KR102474965B1 (ko) 2019-07-01 2022-12-07 오크우드 레버러토리즈, 엘엘씨 마이크로스피어 및 에멀션 제조하기 위한 시스템 및 방법
WO2021108801A2 (en) 2019-11-15 2021-06-03 Consegna Pharma, Inc. Long acting nmda antagonists
IL294089B1 (en) 2019-12-20 2026-07-01 Alar Pharmaceuticals Inc Injectable, long-acting formulations of ketamine pamoate salts
US20210361578A1 (en) 2020-04-03 2021-11-25 University Of Iowa Research Foundation Mek1/2 inhibitor-loaded microparticle formulation

Also Published As

Publication number Publication date
IL300547A (en) 2023-04-01
JP2023538901A (ja) 2023-09-12
EP4199917C0 (en) 2026-01-07
EP4199917A4 (en) 2024-10-30
US12233165B2 (en) 2025-02-25
US20220054420A1 (en) 2022-02-24
EP4199917A1 (en) 2023-06-28
CN115942935B (zh) 2025-09-05
TWI906350B (zh) 2025-12-01
WO2022040130A1 (en) 2022-02-24
CN115942935A (zh) 2023-04-07
CA3191160A1 (en) 2022-02-24
JP7814375B2 (ja) 2026-02-16
AU2021329820A1 (en) 2023-03-09
EP4199917B1 (en) 2026-01-07
TW202227044A (zh) 2022-07-16

Similar Documents

Publication Publication Date Title
CN105377301B (zh) 高药物载量的丁丙诺啡微球和生产其的方法
JP7850071B2 (ja) カリプラジン放出製剤
EP3946272B1 (en) Method for preparing biocompatible polymer-based apixaban-loaded microspheres
KR20220170782A (ko) 세마글루타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 서방형 제제 조성물
JP2016527308A (ja) エンテカビル微小球及びこれを含む非経口投与用医薬組成物
US20160317453A1 (en) High drug load buprenorphine microspheres and method of producing same
JP7814375B2 (ja) ケタミンを含むマイクロスフェア製剤ならびにその製造及び使用方法
CN103893129B (zh) 帕潘立酮缓释微球及其注射剂和该缓释微球的制备方法
US11992559B2 (en) Microsphere formulations comprising lurasidone and methods for making and using the same
ES3061392T3 (en) Microsphere formulations comprising ketamine and methods for making and using the same
US20240216280A1 (en) Microsphere formulations comprising nalmefene andmethods for making and using the same
US20240342115A1 (en) Microsphere formulations comprising ketamine and methods formaking and using the same
US20230225993A1 (en) Microsphere formulations comprising ketamine and methods for making and using the same
WO2023133554A2 (en) Microsphere formulations comprising ketamine and methods for making and using the same
US20250032451A1 (en) Microsphere formulations comprising asenapine and methods for making and using the same
US20240000772A1 (en) Microsphere formulations comprising naltrexone and methods for making and using the same
WO2019079095A2 (en) COMPOSITION AND PROCESS FOR PRODUCTION OF PROLONGED RELEASE PREPARATION OF RISPERIDONE
JP2026507990A (ja) オクトレオチドを含む混合放出プロファイルポリマーミクロスフェア製剤ならびにその製造方法及び使用方法
WO2024163997A1 (en) Microsphere formulations comprising naltrexone and methods for making and using the same
CN116916893A (zh) 包含btk抑制剂的微球制剂及其制备和使用方法
CN116916920A (zh) 包含鲁拉西酮的微球制剂及其制备和使用方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230307

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240814

Comment text: Request for Examination of Application